As estrogen levels drop in women during their 40s and 50s, muscle mass decreases, bone density lowers, and metabolic rate slows.
See the scientific wording
Declining estrogen levels in women during their 40s and 50s cause an acceleration in muscle loss, a reduction in bone density, and a slowing of metabolism.
Strong evidence
Mixed evidence4 moderate-quality studies support this claim, so treat these as early signals rather than settled science.
What the research says
4 studies reviewedSupporting (4)
Randomized Controlled TrialHuman2020
When women go through menopause and their estrogen drops, their muscles don't grow as well when they exercise — but when they get estrogen back through a patch, their muscles grow much more. This shows that low estrogen helps cause muscle loss.
Randomized Controlled TrialHuman2010
When women get older and their estrogen drops, their bones tend to weaken and they get more hot flashes. This study found that a soy supplement helped slow bone loss and reduce hot flashes, which suggests that low estrogen is to blame.
Cohort StudyHuman2026
When women go through menopause and their estrogen drops, their bones get weaker — but this study shows that giving them back estrogen helps strengthen their bones again. This supports the idea that low estrogen causes bone loss.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 4 supporting studies
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
As estrogen levels drop in women during their 40s and 50s, muscle mass decreases, bone density lowers, and metabolic rate slows.
Evidence from Studies
Last searched 2mo ago
Supporting (4)
Community contributions welcome
Transdermal Estrogen Therapy Improves Gains in Skeletal Muscle Mass After 12 Weeks of Resistance Training in Early Postmenopausal Women
When women go through menopause and their estrogen drops, their muscles don't grow as well when they exercise — but when they get estrogen back through a patch, their muscles grow much more. This shows that low estrogen helps cause muscle loss.
When women get older and their estrogen drops, their bones tend to weaken and they get more hot flashes. This study found that a soy supplement helped slow bone loss and reduce hot flashes, which suggests that low estrogen is to blame.
When women go through menopause and their estrogen drops, their bones get weaker — but this study shows that giving them back estrogen helps strengthen their bones again. This supports the idea that low estrogen causes bone loss.
When estrogen drops in middle-aged women, their bones get weaker and muscles lose strength — this study in mice with low estrogen showed the same thing, and fixing their gut bacteria helped reverse it. So yes, low estrogen is linked to these problems.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Estrogen Decline and Changes in Muscle Mass, Bone Density, and Metabolic Rate in Women Aged 40–59
Population: Women aged 40–59 with documented decline in estrogen levels; Intervention: Natural menopausal transition; Comparator: Women with stable estrogen levels; Outcomes: Changes in lean muscle mass, bone mineral density, and resting metabolic rate over time; Duration: Minimum 5 years of longitudinal follow-up.
Double-Blind Placebo-Controlled Trial of Estrogen Replacement on Muscle Mass, Bone Density, and Metabolism in Perimenopausal Women
Population: Women aged 40–55 with declining estrogen; Intervention: Oral or transdermal estrogen therapy; Comparator: Placebo; Outcomes: Change in lean body mass (DXA), lumbar spine BMD (DEXA), and resting energy expenditure (indirect calorimetry); Duration: 24 months.
Longitudinal Cohort Study of Estrogen Trajectories and Changes in Body Composition and Metabolism in Women from Age 40 to 60
Population: Healthy women aged 40 at enrollment; Intervention: None (observational); Comparator: Groups stratified by rate of estrogen decline; Outcomes: Annual measurements of muscle mass, bone density, and metabolic rate over 20 years; Duration: 20 years.
Cross-Sectional Analysis of Estrogen Levels, Muscle Mass, Bone Density, and Metabolic Rate in Women Aged 40–59
Population: Women aged 40–59 recruited at one time point; Intervention: None; Comparator: Groups divided by serum estrogen levels; Outcomes: Single-time-point measurements of muscle mass, bone density, and resting metabolic rate.
In Vitro Effects of Estradiol Depletion on Human Myoblast and Osteoblast Metabolic Activity and Protein Synthesis
Population: Human primary myoblasts and osteoblasts; Intervention: Culture media with low vs. normal estradiol concentrations; Comparator: Control media with physiological estradiol; Outcomes: Rates of myofibrillar protein synthesis, osteocalcin secretion, and mitochondrial respiration; Duration: 72–120 hours.